SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...
In this Healio Video Perspective from Hawaiian Eye 2026, Michael Greenwood, MD, of Vance Thompson Vision, discusses the InSightVR system from GreenMan.InSightVR is a virtual reality tool that shows ...
LOS ANGELES — In patients who previously underwent refractive surgery or corneal inlay implantation, the small-aperture IC-8 Apthera IOL demonstrated positive vision outcomes, Robert E. Ang, MD, told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback